Patents by Inventor James Thomson

James Thomson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200080059
    Abstract: Methods for generating and using hematopoietic progenitor cells are described.
    Type: Application
    Filed: September 6, 2019
    Publication date: March 12, 2020
    Inventors: James A. Thomson, Jue Zhang
  • Publication number: 20200071664
    Abstract: Methods for derivation, culture, and maturation of small hepatic progenitor cells are described.
    Type: Application
    Filed: August 30, 2019
    Publication date: March 5, 2020
    Inventors: James A. Thomson, Srikumar Sengupta
  • Patent number: 10463721
    Abstract: Provided are chimeric arginine deiminases, including pegylated chimeric arginine deiminases, and related compositions and methods of use thereof, including methods of treating cancer.
    Type: Grant
    Filed: March 18, 2015
    Date of Patent: November 5, 2019
    Assignee: TDW Group
    Inventors: Bor-Wen Wu, Robert Almassy, Wei He, Richard E. Showalter, Jiaojuan He, Yunyun Guo, James A. Thomson
  • Publication number: 20190330654
    Abstract: Methods for reprogramming primate somatic cells to pluripotency using an episomal vector that does not encode an infectious virus are disclosed. Pluripotent cells produced in the methods are also disclosed.
    Type: Application
    Filed: December 4, 2018
    Publication date: October 31, 2019
    Inventors: James Thomson, Junying Yu
  • Patent number: 10450251
    Abstract: There is described a method of preparing a compound of formula I, and optical isomers thereof; in which R1 is hydrogen or a protecting group; said method comprising oxidizing verbenone and optical isomers thereof.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: October 22, 2019
    Assignee: E-THERAPEUTICS PLC
    Inventors: Vijaya Bhasker Gondi, James Thomson Loch, III, Nicholas John Holman, Steven James Collier
  • Patent number: 10437584
    Abstract: A command interface for a software application is implemented on a client computer. A first definition of the command interface is received from a server computer. The first definition includes rules for encoding the command interface on a web browser. A conversion of the first definition to a second definition is performed. The second definition includes language for encoding the command interface on a user interface of the software application. The second definition is used to render the command interface on the user interface of the software application.
    Type: Grant
    Filed: August 17, 2015
    Date of Patent: October 8, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Michael J. McCormack, Nicholas James Thomson, Andrew Nathan Magee, Navin Ishwar Thadani, Shashi Ranjan
  • Patent number: 10435666
    Abstract: The first method to cause a culture of human and other primate stem cells to directly and uniformly differentiate into a committed cell lineage is disclosed. Treatment of primate stem cells with a single protein trophoblast induction factor causes the cells to transform into human trophoblast cells, the precursor cells of the placenta. Several protein factors including bone morphogenic protein 4 (BMP4), BMP2, BMP7, and growth and differentiation factor 5 can serve as trophoblast-inducting factors.
    Type: Grant
    Filed: June 2, 2008
    Date of Patent: October 8, 2019
    Assignee: WiCell Research Institute, Inc.
    Inventors: Ren-He Xu, James A. Thomson
  • Publication number: 20190258692
    Abstract: Systems and methods are provided methods for providing an online interface for displaying hierarchically or logically arranged user-generated content. One method including receiving, from a first user over a network, topical user-generated electronic content, the topical user-generated electronic content being related to a topic of a web page; displaying the topical user-generated electronic content received from the first user on the web page; receiving, from a second user over the network, responsive user-generated electronic content and an indication of a desire to post the responsive user-generated electronic content on the web page in association with the topical user-generated electronic content; and displaying, adjacent to the topical user-generated electronic content on the web page, a user element or link that a third user can manipulate to display the responsive user-generated electronic content adjacent to the topical user-generated electronic content.
    Type: Application
    Filed: May 3, 2019
    Publication date: August 22, 2019
    Applicant: Oath Inc.
    Inventors: MacGregor James THOMSON, Thomas BIEGELEISEN, Siobhan DOOLEY
  • Patent number: 10324999
    Abstract: Systems and methods are provided methods for providing an online interface for displaying hierarchically or logically arranged user-generated content. One method including receiving, from a first user over a network, topical user-generated electronic content, the topical user-generated electronic content being related to a topic of a web page; displaying the topical user-generated electronic content received from the first user on the web page; receiving, from a second user over the network, responsive user-generated electronic content and an indication of a desire to post the responsive user-generated electronic content on the web page in association with the topical user-generated electronic content; and displaying, adjacent to the topical user-generated electronic content on the web page, a user element or link that a third user can manipulate to display the responsive user-generated electronic content adjacent to the topical user-generated electronic content.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: June 18, 2019
    Assignee: Oath Inc.
    Inventors: MacGregor James Thomson, Thomas Biegeleisen, Siobhan Dooley
  • Patent number: 10296914
    Abstract: On a client computer, customer relationship management software is integrated into a messaging application that includes a user interface. Customer relationship management (CRM) information is received from a server computer. An automatic determination is made as to whether the received CRM information is to be cached on the client computer. When it is determined that the CRM information is to be cached on the client computer, the CRM information is cached in a cache on the client computer. When at least some of the CRM information is cached on the client computer, the cached CRM information is displayed as a view on the client computer. The display of the CRM information is integrated into the user interface of the messaging application program.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: May 21, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Michael J. McCormack, Nicholas James Thomson, Dmitri Davydok, Indrojit Deb, David Robert Shutt
  • Publication number: 20190127306
    Abstract: Disclosed are new polycyclic carbogenic molecules and their methods of synthesis. The new polycyclic carbogenic molecules may be utilized in anti-cancer therapies. In particular, the polycyclic carbogenic molecules may be formulated as pharmaceutical compositions that comprise the small molecules, which compositions may be administered in methods of treating and/or preventing cell proliferative diseases and disorders such as cancer. The new polycyclic carbogenic molecules may be prepared from vinyl- or allyl-substituted cyclohexenone precursors via preparation of a silyl bis-enol ether intermediate.
    Type: Application
    Filed: September 21, 2018
    Publication date: May 2, 2019
    Applicant: Northwestern University
    Inventors: Regan James Thomson, Emily E. Robinson
  • Publication number: 20190106675
    Abstract: The present invention relates to methods for reprogramming a somatic cell to pluripotency by administering into the somatic cell at least one or a plurality of potency-determining factors. The invention also relates to pluripotent cell populations obtained using a reprogramming method.
    Type: Application
    Filed: September 21, 2018
    Publication date: April 11, 2019
    Inventors: James A. Thomson, Junying Yu
  • Publication number: 20190078054
    Abstract: The present invention relates to methods for deriving human hematopoietic progenitors, primitive macrophages, and microglial cells from human pluripotent stem cells. In particular, provided herein are highly efficient and reproducible methods of obtaining human primitive macrophages and microglia from human pluripotent stem cells, where the primitive macrophages and microglia can be suitable for clinically relevant therapeutic applications.
    Type: Application
    Filed: September 21, 2018
    Publication date: March 14, 2019
    Inventors: James A. Thomson, Nicholas E. Propson, Michael P. Schwartz, Zhonggang Hou, Gene I. Uenishi, Igor I. Slukvin, William L. Murphy, Jue Zhang
  • Patent number: 10223698
    Abstract: A customer relationship management (CRM) system utilizes a form definition, user interface (UI) definitions, and UI code to generate Web pages for interacting with CRM data. A CRM plug-in is configured to execute in conjunction with a personal information manager (PIM) client application and to utilize the same form definition, UI definitions, and UI code utilized by the CRM system to generate the Web-based CRM interface. The UI definitions are utilized to present UI controls for performing CRM-related functionality in the context of a UI generated by the PIM client application. The UI code utilized by the CRM system to implement Web-based UI controls can be utilized to implement the UI controls in the context of the PIM client application. The form definition utilized by the CRM system might be utilized to display CRM fields in the UI presented by the PIM client application.
    Type: Grant
    Filed: May 25, 2016
    Date of Patent: March 5, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Wayne Carlyle Walsh Parker, III, Michael J. McCormack, Tobin James Zerba, Praveen Upadhyay, Nicholas James Thomson, Sharad Bajaj
  • Publication number: 20190010461
    Abstract: Methods of using a small molecule MYH11 agonist to inhibit intimal hyperplasia and to maintain a contractile phenotype in vitro and in vivo are described. Also described herein are methods for generating human contractile smooth muscle cells from human pluripotent stem cells under defined conditions in the presence of the small molecule MYH11 agonist.
    Type: Application
    Filed: July 6, 2018
    Publication date: January 10, 2019
    Inventors: James A. Thomson, Jue Zhang
  • Publication number: 20180354876
    Abstract: There is described a method of preparing a compound of formula I, and optical isomers thereof; in which R1 is hydrogen or a protecting group; said method comprising oxidising verbenone and optical isomers thereof.
    Type: Application
    Filed: December 2, 2016
    Publication date: December 13, 2018
    Applicant: e-Therapeutics plc
    Inventors: Vijaya Bhasker Gondi, James Thomson Loch, III, Nicholas John Holman, Steven James Collier
  • Publication number: 20180308579
    Abstract: Medical devices, systems, and methods related thereto having hierarchical restrictive access schemes are provided. Such medical devices, systems, and methods may include an in vitro analyte monitoring device, an in vivo analyte monitoring device, and/or a drug infusion device having, among other features, hierarchical permission schemes allowing individual access levels thereto.
    Type: Application
    Filed: June 25, 2018
    Publication date: October 25, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Christopher V. Reggiardo, Namvar Kiaie, James Thomson
  • Patent number: 10106772
    Abstract: The present invention relates to methods for reprogramming a somatic cell to pluripotency by administering into the somatic cell at least one or a plurality of potency-determining factors. The invention also relates to pluripotent cell populations obtained using a reprogramming method.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: October 23, 2018
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: James A. Thomson, Junying Yu
  • Publication number: 20180296690
    Abstract: Provided are conjugates of an arginine deiminase (ADI) and a Tumor Necrosis Factor (TNF) superfamily ligand, and related compositions and methods of use thereof. Also provided are conjugates of a hexameric polypeptide and a trimeric polypeptide, conjugates of a first and second trimeric polypeptide, and related compositions and methods of use thereof.
    Type: Application
    Filed: March 29, 2018
    Publication date: October 18, 2018
    Inventors: Elena BRIN, Robert J. ALMASSY, Richard E. SHOWALTER, James A. THOMSON
  • Publication number: 20180296652
    Abstract: Provided are lyophilized formulations comprising pegylated arginine deiminase (ADI-PEG) and related reconstituted liquid compositions and methods of using the compositions for arginine depletion therapies, including for the treatment of various cancers.
    Type: Application
    Filed: November 2, 2017
    Publication date: October 18, 2018
    Inventors: Bor-Wen Wu, James Thomson, Wen-Chin Tsai